Depti Bellani

Depti Bellani

Auto-generated profile, based on publicly available information

Depti Bellani

Department of Medical Affairs, Esthetic Creations International Pvt. Ltd. (ECIPL), Mumbai, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2024 in Journal of Cutaneous and Aesthetic Surgery
Verified
Journal Article
Open access
RJRushika Jain
Rushika Jain
STSanika Tanawde
Sanika Tanawde
SJSanjay Joshi
Sanjay Joshi
CNCharudatta Naik
Charudatta Naik
AGAarti Garad
Aarti Garad
DCDeepti Chablani
Deepti Chablani
Lip augmentation is among the most popular cosmetic procedures done today. Advancements in trustworthy techniques have made it feasible to alter the visual characteristics of the lips through the utilization of various injectable substances and surgical procedures. However, there is a lack of standardization in these techniques. The purpose of this review is to focus on novel dermal filler injection and surgical techniques for lip augmentation. We did a scoping review of the literature using PubMed, Embase, and the Google Scholar database to identify all original articles published up to June 2023, assessing new techniques that focus on lip augmentation. In our review, only two studies out of seven included studies were surgical whereas the other five studies were non-surgical. This suggests that injection of dermal fillers is currently the most opted technique performed. This review suggests that incorporating perioral rejuvenation into the plan for lower facial surgery can help to complete the youthful look sought by patients. Injectable fillers provide excellent but short-term benefits and additional options such as Modified upper lip lift and French kiss techniques exist that offer the patient permanent improvements at a low cost.

30 January 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
DSDebraj Shome
Debraj Shome
MMMamata Mishra
Mamata Mishra
APAshwin Prabhughate
Ashwin Prabhughate
DBDepti Bellani
Depti Bellani
RPRaji Patil
Raji Patil
RKRinky Kapoor
Rinky Kapoor

16 December 2025 in ADMET and DMPK
Verified
Journal Article
Open access
PDF file
RKRinky Kapoor
Rinky Kapoor
DBDepti Bellani
Depti Bellani
RPRaji Patil
Raji Patil
DBDebalina Bose
Debalina Bose
MPMadhuri Pola
Madhuri Pola
DSDebraj Shome
Debraj Shome
Background and purpose: Non-scarring alopecia, principally androgenetic alopecia and alopecia areata is highly prevalent and psychologically burdensome; androgenetic alopecia is androgen-driven, whereas alopecia areata is autoimmune. This review synthesizes genetic architecture and pathway biology to outline a precision framework for targeted interventions. Experimental approach: We reviewed full-text studies from the past decade across PubMed, Web of Science and Google Scholar, applying explicit inclusion/ex­clusion criteria; emphasis was placed on Genome wide association studies and Next generation sequencing findings, immune and androgen-axis biology, environmental modifiers, and therapeutic evidence (conven­tional, targeted, and regenerative), alongside artificial Intelligence-enabled diagnostics. Key results: Andro­genetic alopecia risk converges on androgen-receptor signalling and related loci, with perifollicular inflam­mation and oxidative stress as modifiers; finasteride remains a cornerstone therapy. Alopecia areata reflects polygenic immune dysregulation (e.g. Human leukocyte antigen/cytokine axes) with Janus Kinase-pathway inhibition yielding robust regrowth; across phenotypes, wingless-related integration sit/β-catenin and stem-cell programs are central targets. Regenerative options (Protein Rich Plasma, stem-cell/exosome appro­aches) and artificial Intelligence-assisted stratification are emerging adjuncts. Conclusion: A pathway-guided, genotype and phenotype-informed strategy, targeting the androgen axis for androgenetic alopecia, immune circuits for alopecia areata, and adding regenerative or microenvironmental therapies where indicated-promises earlier diagnosis and more durable, individualized outcomes, especially as genome-wide association study/next-generation sequencing and artificial Intelligence tools are integrated into care.

14 July 2025 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Closed access
PDF file
DBDepti Bellani
Depti Bellani
MSMohit Pal Singh
Mohit Pal Singh
SJSanjay Joshi
Sanjay Joshi
BRBhagwandas Rai
Bhagwandas Rai
NBNikhil Bhanushali
Nikhil Bhanushali
DBDebalina Bose
Debalina Bose

21 January 2026 in Pharmaceutical Medicine
Verified
Journal Article
Closed access
PDF file
DBDebalina Bose
Debalina Bose
DBDepti Bellani
Depti Bellani
RPRaji Patil
Raji Patil
KJKhusboo Jamasbi
Khusboo Jamasbi
RKRinky Kapoor
Rinky Kapoor
DSDebraj Shome
Debraj Shome

23 July 2025 in Journal of Maxillofacial and Oral Surgery
Verified
Journal Article
Closed access
PDF file
SJSanjay Joshi
Sanjay Joshi
RKRashmi Kumari
Rashmi Kumari
AGAarti Garad
Aarti Garad
DBDepti Bellani
Depti Bellani
SBSachin Bagade
Sachin Bagade
BMBhupendra Mhatre
Bhupendra Mhatre